| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/09/2002 | US20020054902 Liposomes containing therapeutic genes are conjugated to targeting agents to provide transport of encapsulated gene across blood-retainal barrier and plasma membrane of ocular cell, where this gene expresses encoded therapeutical agent |
| 05/09/2002 | US20020054887 Toxin has at least one amino acid change and is substantially non-lethal compared with wild type SPE-A toxin; for vaccines |
| 05/09/2002 | US20020054881 Variants can be used in specific immunotherapy of allergic pathologies caused by dust mites |
| 05/09/2002 | US20020054878 Anti-IgE antibodies |
| 05/09/2002 | US20020054877 Mammalian cytokine; related reagents |
| 05/09/2002 | US20020054876 Treatment of Alzheimer's disease |
| 05/09/2002 | US20020054870 A peptide containing atleast 6 amino acid residues, having 70% homology with part or all of the sequence containing specific 14 amino acids |
| 05/09/2002 | US20020053259 Compositions and methods for removing pollutants from contaminated materials |
| 05/08/2002 | EP1203827A2 Polymorphisms in the human KDR gene |
| 05/08/2002 | EP1203826A2 Oligonucleotide for detection of HIV-1 and detection method |
| 05/08/2002 | EP1203824A2 Reaction-based selection for expression of and concentration of catalytic moieties |
| 05/08/2002 | EP1203819A2 Anti-inflammatory vectors |
| 05/08/2002 | EP1203818A2 DNA Strands useful for the synthesis of xanthophylls and the process for producing the xanthophylls |
| 05/08/2002 | EP1203817A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 05/08/2002 | EP1203816A1 Amyloid beta protein agglutination controlling factor |
| 05/08/2002 | EP1203813A2 Attenuated pestiviruses |
| 05/08/2002 | EP1203812A2 Attenuated pestiviruses |
| 05/08/2002 | EP1203775A2 Lymphocyte chemoattractant factor and uses thereof |
| 05/08/2002 | EP1203337A2 Profile searching in nucleic acid sequences using the fast fourier transformation |
| 05/08/2002 | EP1203240A2 Laboratory robot and method and reagent kit for isolating nucleic acids |
| 05/08/2002 | EP1203239A2 Use of a polypeptide for detecting, preventing or treating a pathological condition associated with a degenerative, neurological or autoimmune disease |
| 05/08/2002 | EP1203238A2 Methods of generating protein expression arrays and the use thereof in rapid screening |
| 05/08/2002 | EP1203214A1 Optical system analysis of cells |
| 05/08/2002 | EP1203101A1 Ppar delta links apc to chemopreventive drugs |
| 05/08/2002 | EP1203100A2 Methods for detecting mutations using primer extension |
| 05/08/2002 | EP1203099A2 Methods and apparatus for template capture and normalization for submicroliter reaction |
| 05/08/2002 | EP1203097A2 Pcr-based detection and quantification of tapesia yallundae and tapesia acuformis |
| 05/08/2002 | EP1203096A2 Integration of biochemical protocols in a continuous flow microfluidic device |
| 05/08/2002 | EP1203095A2 Screen for nitric oxide synthase modulators |
| 05/08/2002 | EP1203094A2 Method for marking solid, liquid and gaseous substances |
| 05/08/2002 | EP1203093A1 2'-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligands |
| 05/08/2002 | EP1203092A1 Antisense modulation of map kinase kinase 6 expression |
| 05/08/2002 | EP1203089A1 A METHOD TO CONTROL CELLULAR (3R)-HYDROXYACYL-CoA ESTERS, PRECURSOR MOLECULES FOR POLYHYDROXYALKANOATE SYNTHESIS IN GENETICALLY MODIFIED ORGANISMS |
| 05/08/2002 | EP1203088A2 Conditionally controlled, attenuated hiv vaccine |
| 05/08/2002 | EP1203087A2 Transgenically modified plant cells and plants having modified gbssi- and be-protein activity |
| 05/08/2002 | EP1203086A2 Mites-like element and transcriptional activation element |
| 05/08/2002 | EP1203085A2 Aspartate kinase |
| 05/08/2002 | EP1203084A1 Microencapsulated nitric oxide synthase source |
| 05/08/2002 | EP1203083A1 Chloramphenicol biosynthetic pathway and gene cluster characterization |
| 05/08/2002 | EP1203082A1 Recombinant high molecular weight major outer membrane protein of moraxella |
| 05/08/2002 | EP1203081A2 Human intracellular signaling molecules |
| 05/08/2002 | EP1203080A2 Isolation of biomolecules |
| 05/08/2002 | EP1203079A2 Method for enhancing cellulose and modifying lignin biosynthesis in plants |
| 05/08/2002 | EP1203077A1 TRANSGENIC PLANTS EXPRESSING i PHOTORHABDUS /i TOXIN |
| 05/08/2002 | EP1203026A1 Binding moieties for fibrin |
| 05/08/2002 | EP1203024A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 05/08/2002 | EP1203023A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 05/08/2002 | EP1203022A1 Novel genetic sequences encoding steroid and juvenile hormone receptor polypeptides and uses therefor |
| 05/08/2002 | EP1203021A2 NEW SEQUENCE VARIANTS OF THE HUMAN $g(b)1-ADRENORECEPTOR GENES AND USE THEREOF |
| 05/08/2002 | EP1203020A1 Modulation of human sodium channels in dorsal root ganglia |
| 05/08/2002 | EP1203018A1 26 human prostate and prostate cancer associated proteins |
| 05/08/2002 | EP1203016A2 Proteases and protease inhibitors |
| 05/08/2002 | EP1203015A2 Human chaperone proteins |
| 05/08/2002 | EP1203014A2 Peptide antagonists of factor viia |
| 05/08/2002 | EP1203013A1 Kinase blocking polypeptides and uses thereof |
| 05/08/2002 | EP1203010A1 Antisense modulation of fadd expression |
| 05/08/2002 | EP1203009A1 Antisense modulation of jun n-terminal kinase kinase-1 expression |
| 05/08/2002 | EP1203008A1 Nucleic acid ligands to cd40ligand |
| 05/08/2002 | EP1203007A1 Nucleic acid ligands to hepatocyte growth factor/scatter factor (hgf/sf) or its receptor c-met and to integrins |
| 05/08/2002 | EP1203006A1 Conditional-selex |
| 05/08/2002 | EP1203005A2 25 human secreted proteins |
| 05/08/2002 | EP1203004A1 HIGH AFFINITY TGF$g(g) NUCLEIC ACID LIGANDS AND INHIBITORS |
| 05/08/2002 | EP1202744A2 PRODUCTION OF rhPBGD AND NEW THERAPEUTIC METHODS FOR TREATING PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP) AND OTHER PORPHYRIC DISEASES |
| 05/08/2002 | EP1202741A1 Neurotropic virus transport |
| 05/08/2002 | EP1202629A2 Insect control system |
| 05/08/2002 | EP1092021A4 Npy-y7 receptor gene |
| 05/08/2002 | EP1062366A4 Detection of neoplasia by analysis of saliva |
| 05/08/2002 | EP1011319A4 A method of treatment and an animal model useful for same |
| 05/08/2002 | EP0998299A4 ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF |
| 05/08/2002 | EP0996719A4 A novel nucleic acid molecule |
| 05/08/2002 | EP0915648B1 Methods and compositions for the selective modification of nucleic acids |
| 05/08/2002 | EP0895545A4 Novel protein - traf6 |
| 05/08/2002 | EP0789783B1 Antigen binding peptides (abtides) from peptide libraries |
| 05/08/2002 | EP0781351A4 In vitro method for predicting the evolutionary response of hiv protease to a drug targeted thereagainst |
| 05/08/2002 | EP0721505B1 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 05/08/2002 | EP0708653B1 Assay and reagents for identifying anti-proliferative agents |
| 05/08/2002 | EP0681613B1 Ribozyme amplified diagnostics |
| 05/08/2002 | EP0662136B1 Cleaning compositions containing novel alkaline proteases |
| 05/08/2002 | EP0629240B1 Altered antibodies, products and processes relating thereto |
| 05/08/2002 | EP0627932B1 Antibody construct |
| 05/08/2002 | EP0625053B1 Urease-based vaccine against helicobacter infection |
| 05/08/2002 | DE10054878A1 Natriumkanäle vom Typus der peripheren Nerven Sodium channels of the type of peripheral nerves |
| 05/08/2002 | DE10053781A1 Kernexportreportersystem Nuclear export reporter system |
| 05/08/2002 | DE10053251A1 New protein or peptide comprising epitope of plasminogen activator inhibitor-1, useful for screening substance for treating thromboembolic and cardiovascular diseases, cancer or related diseases |
| 05/08/2002 | DE10053224A1 Verfahren zur Exposition von Peptiden und Polypeptiden auf der Zelloberfläche von Bakterien A process for the exposure of peptides and polypeptides on the cell surface of bacteria |
| 05/08/2002 | DE10051259A1 Non-human mammal with altered pituitary adenylate cyclase-activating polypeptide receptor, useful e.g. as screening agents for treating e.g. learning difficulties |
| 05/08/2002 | CN1348502A Crystal structure of cPLAz and methods of identifying agonists and antagonists using same |
| 05/08/2002 | CN1348498A Novel Nucleic acid transferring agents, compsoitions containing them and uses |
| 05/08/2002 | CN1348497A 载体 Carrier |
| 05/08/2002 | CN1348496A Viral vaccine |
| 05/08/2002 | CN1348495A Cotton leaf curl virus (CLCuV) promoter and its use |
| 05/08/2002 | CN1348494A Polynucleotide synthesis using a processing enzyme |
| 05/08/2002 | CN1348493A Carriers having biological substance |
| 05/08/2002 | CN1348465A Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 05/08/2002 | CN1348464A Compositions and methods using lactadherin or variants thereof |
| 05/08/2002 | CN1348463A Immunological herpes simplex virus antigens and methods for use thereof |
| 05/08/2002 | CN1348376A Method for validating/invalidating target(s) and pathways |
| 05/08/2002 | CN1348374A Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4-metabolic pathway, and inhibitors of lipid metabolism |
| 05/08/2002 | CN1348332A Vaccines and gene therapy compositions and methods of making and using the same |
| 05/08/2002 | CN1348102A Plasmid and its constitution method and application in determining HIV carrying amount |